1.14.20.1: deacetoxycephalosporin-C synthase
This is an abbreviated version!
For detailed information about deacetoxycephalosporin-C synthase, go to the full flat file.
Word Map on EC 1.14.20.1
-
1.14.20.1
-
clavuligerus
-
chrysogenum
-
acremonium
-
isopenicillin
-
penicillium
-
beta-lactams
-
epimerase
-
cephamycins
-
cephalosporium
-
ring-expansion
-
7-aminodeacetoxycephalosporanic
-
pcbab
-
ironii
-
cephem
-
lactamdurans
-
synthesis
-
7-adca
-
2-oxoglutarate-dependent
-
cephalexin
-
carbenicillin
-
doacs
-
biotechnology
-
medicine
- 1.14.20.1
- clavuligerus
- chrysogenum
- acremonium
- isopenicillin
- penicillium
- beta-lactams
-
epimerase
-
cephamycins
- cephalosporium
-
ring-expansion
-
7-aminodeacetoxycephalosporanic
-
pcbab
-
ironii
-
cephem
- lactamdurans
- synthesis
-
7-adca
-
2-oxoglutarate-dependent
- cephalexin
- carbenicillin
-
doacs
- biotechnology
- medicine
Reaction
Synonyms
acDAOC/DACS, cefE, cefEF, Cephalosporin biosynthesis expandase/hydroxylase, DAOC synthase, DAOC/DAC synthase, DAOC/DACS, DAOCS, deacetoxy/deacetylcephalosporin C synthase, deacetoxycephalosporin C synthase, deacetoxycephalosporin-C synthase, deacetoxycephalosporin-C synthetase, deacetoxycephalosporin/deacetylcephalosporin C synthase, expandase, expendase, penicillin N expandase, scDAOCS
ECTree
Advanced search results
Crystallization
Crystallization on EC 1.14.20.1 - deacetoxycephalosporin-C synthase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
crystal structure of the DAOC synthase is in trimeric form, C-terminal end of the protein is responsible for the oligomerization process, addition of Fe2+ or 2-oxoglutarate shifts the equilibrium toward the monomeric form that appears to be the active form in solution
-
crystallization of mutant delta R306, with Fe2+ and 2-oxoglutarate, 2.1 A resolution
crystallization of mutant delta R307A, with Fe2+, succinate and CO2, 1.96 A resolution
crystallization of wild-type enzyme and of the DELTAR306 mutant complexed with iron(II) and 2-oxoglutarate to 2.1 A and the DELTAR306A mutant complexed with iron(II), succinate and unhydrated carbon dioxide to 1.96 A
crystallization with 5-hydroxy-4-ketovaleric acid, 1.53 A resolution
crystallization with Fe(II) and succinate , 1.5 A resolution
crystallization with Fe(II) and deacetoxycephalosporin C, 1.7 A resolution
crystallization with Fe(II) and penicillin G, 1.6 A resolution
crystallization with Fe(II), 2-oxoglutarate and ampicillin, 1.5 A resolution
crystallization with Fe(II), 2-oxoglutarate and penicillin G, 1.7 A resolution
crystallization with Fe2+ and 2-oxoglutarate, 1.5 A resolution, the crystal structure of scDAOCS complexed with 2-oxoglutarate reveals that the 5-carboxylate of 2-oxoglutarate is stabilized by electrostatic interaction with the side chain of R258
hanging drop method, recombinant enzyme expressed in Escherichia coli
quantum mechanical calculations of the first part of the reaction based on the high-resolution structures of the active site and its complexes with ligands
R258Q mutant, crystallization with Fe(II) and alpha-keto-beta-methylbutanoate, 1.5 and 1.6 A resolution
recombinant enzyme expressed in Escherichia coli, high-resolution structures for apoenzyme, the enzyme complexed with Fe(II), and with Fe(II) and 2-oxoglutarate
recombinant N-terminally His-tagged wild-type and C-terminally truncated mutant enzymes, free enzyme, or complexing with Fe2+, or Fe2+/ampicillin, hanging drop vapour diffusion method, 4°C, precipitant solution: 100 mM HEPES-NaOH, pH 8.0, 0.9-1.1 M ammonium sulfate, the reservoir solution is covered with oil to retard the evaporation, cryoprotection by 30% v/v ethylene glycol in precipitant solution, X-ray structure determination and analysis at 2.3 A resolution, molecular modeling
with N-terminal His tag, crystallization with ampicillin and Fe2+, 2.7 A resolution
with N-terminal His tag, crystallization with deacetoxycephalosporin C and Fe2+, 3.0 A resolution